<?xml version="1.0" encoding="UTF-8"?>
<p id="p0090">The first patient to present with COVID-19 in the U.S. was treated with intravenous remdesivir under the compassionate use clause after developing pneumonia in January 2020 [
 <xref rid="bb0185" ref-type="bibr">37</xref>]. This 35-year-old male had been infected during travel to Wuhan and returned to the U.S. where he was hospitalized for more than 12Â days. He was treated with intravenous remdesivir on the seventh day, and his condition was reportedly improving on the eighth day. No adverse events related to remdesivir use were noted. The case report was written prior to the patient's discharge.
</p>
